课题基金 / 基金详情

Bridging the Gaps: Systems-level approaches to antimicrobial resistance

Bridging the Gaps: Systems-level approaches to antimicrobial resistance
弥合差距:解决抗菌素耐药性的系统级方法
批准号:
EP/M027333/1
负责人:
John King
金额:
$62.59万
依托单位:
依托单位国家:
英国
项目类别:
Research Grant
财政年份:
2015
资助国家:
英国
项目状态:
已结题
起止时间:
2015 至 --

项目摘要

项目成果

John King的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The problem of antimicrobial resistance (AMR) is an increasing challenge, not only in the context of healthcare but also in, for example, food safety and agriculture. The prevalence of resistant bugs such as MRSA has received widespread media coverage and the problems relating to resistance are now more widely recognised than ever before, as is the importance of developing new approaches, particularly given the increase in issues associated with multidrug resistant species. The current proposal seeks to drawn on wide-ranging applicable expertise in engineering and the physical sciences that, in collaboration with biological-science researchers, clinicians and industry, offers hitherto unexploited opportunities to contribute significantly to addressing these very significant challenges.We shall accordingly deliver a programme of activities that promotes new interdisciplinary collaborations across traditional boundaries between engineering, the physical sciences and the biological sciences. The University of Nottingham has an outstanding history of such discipline-bridging activities, as well as of research relevant to AMR, and will bring this experience to bear upon the challenge of AMR. The primary mechanism for promoting new research collaborations will be that of themed Sandpits, building on the success of the Mathematics-in-Medicine Study Groups pioneered by the University in 2000 (and subsequently spawning the Mathematics-in-the-Plant-Sciences Study Groups and others). In these, presenters from the biological sciences, clinical medicine or industry will describe issues that could benefit from new approaches drawn from engineering and the physical sciences; intensive brain-storming work on these topics will identify the skills needed and establish the relevant cross-disciplinary teams; seed funding will then be provided for the most promising projects identified. While the process is now well-established, the outcomes of such workshops are very far from predictable and the aggregation of the range of disciplines outlined above should ensure that innovative approaches come to the fore. Other mechanisms will include Challenge Days (modifying the successful approach of the Industry Challenge Days held by the Business School to ensure that research developments align with the needs of potential end users), discipline-hopping secondments, speed-networking sessions, cross-disciplinary workshops (focussing on specific methodologies, to enhance further the opportunities for identifying potential crossovers between research fields) and annual showcases in the form of a launch event and a concluding 'forward-look' workshop. These activities will be augmented by a Visiting-Scholar programme whereby leading experts in complementary areas will contribute their expertise to the initiative.Funding from the programme will be assigned in competition to multidisciplinary projects judged on their research excellence and their capacity to contribute to addressing AMR challenges. The programme's Strategy Group will be responsible for assessing applications and for monitoring progress; the activities outlined above are specifically designed (in particular by bringing together researchers from diverse disciplines) to ensure that the research ideas developed are highly innovative and that the associated projects have the required mix of research expertise. The programme will be very explicitly outward-facing, drawing extensively on input from clinicians, industrialists and other potential end users, as well as interacting with complementary research elsewhere. In combination with the excellence and innovation of the research developed, such collaborations will ensure the sustainability of the initiative.
期刊论文(10)
专著(0)
科研奖励(0)
会议论文
DOI: 10.3390/bios11070238
发表时间: 2021-07-14
期刊: Biosensors
影响因子: --
作者: [Chauhan VM, Elsutohy MM, McClure CP, Irving WL, Roddis N, Aylott JW]
通讯作者: Aylott JW
Nanoimpedimetry with plasmonic nanoparticles
使用等离子体纳米颗粒进行纳米阻抗测量
DOI: 10.26434/chemrxiv-2022-8z5jj
发表时间: 2022
期刊:
影响因子: --
作者: [Abayzeed S]
通讯作者: Abayzeed S
DOI: 10.1364/boe.395474
发表时间: 2020-11-01
期刊: Biomedical optics express
影响因子: 3.4
作者: [Abayzeed SA]
通讯作者: Abayzeed SA
DOI: 10.1007/s11538-021-00865-9
发表时间: 2021-03-01
期刊: Bulletin of mathematical biology
影响因子: 3.5
作者: [Lanyon CW, King JR, Stekel DJ, Gomes RL]
通讯作者: Gomes RL
The North Atlantic Climate System Integrated Study (ACSIS) - 1 year extension
  • 批准号:
    NE/V013246/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $42.5万
  • 财政年份:
    2021
  • 负责人:
    John King
  • 依托单位:
The North Atlantic Climate System Integrated Study
  • 批准号:
    NE/N018028/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $173.44万
  • 财政年份:
    2016
  • 负责人:
    John King
  • 依托单位:
Collaborative Research: A 650,000 year record of hydroclimate in the Western Pacific Warm Pool: Scientific Drilling at Lake Towuti, Indonesia
  • 批准号:
    1401733
  • 项目类别:
    Continuing Grant
  • 资助金额:
    $7.0万
  • 财政年份:
    2014
  • 负责人:
    John King
  • 依托单位:
Systems biology of the butanol-producing Clostridium acetobutylicum: new source of biofuel and chemicals/COSMIC2
  • 批准号:
    BB/I004513/1
  • 项目类别:
    Research Grant
  • 资助金额:
    $29.41万
  • 财政年份:
    2010
  • 负责人:
    John King
  • 依托单位:
国内基金
海外基金
岩藻糖基化修饰调控GAPs介导的Treg-菌群稳态防止重症急性胰腺炎细菌易位的机制研究
  • 批准号:
    JCZRQN202500102
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
针刺促进猫脊髓可塑性变化的分子基础-GAPs基因的表达
  • 批准号:
    39400177
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    5.0万元
  • 批准年份:
    1994
  • 负责人:
    董红心
  • 依托单位: